Filters

Eslicarbazepine manufacturers

Filters

None products found

eslicarbazepine

Tablets 200 mg, 400 mg, 600 mg. 800 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #287

A globally-oriented pharmaceutical manufacturer operating with integrated in-house development and supply chain capabilities for pharmaceutical products. The company offers over 180 medicines across more than 10 dosage forms (tablets, capsules, powders, drops, inhalers, patches, eye-drops) and serves markets in more than 80 countries. Its manufacturing network includes a European production site with EU batch testing and release of pharmaceutical products, and a specialised facility in India for high-potency drugs under a GMP-compliant environment.

Manufacturer usually replies in 22 days

eslicarbazepine

Tablets 400 mg, 800 mg, 1200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Value-added medicine
Manufacturer #573
A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, Africa, and Asia for 30+ years. Key production lines are Rx and nutraceuticals. Main therapeutic areas include CNS and respiratory. Main dosage forms include sterile forms and oral solid. The company's production lines are EU GMP-compliant. The company owns 10+ branches in Europe.

Manufacturer usually replies in 34 days

eslicarbazepine

Tablets, film coated 200 mg, 800 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Iceland
GMP approvals
EU GMP
Manufacturer #28915

This company specializes in generic pharmaceuticals within the EU region. They offer out-licensing and contract manufacturing services to pharmaceutical companies seeking high-quality production from a reliable European partner. Their facility utilizes green energy sources, highlighting their commitment to sustainability. While specific therapy areas and product details are not provided, they likely focus on various dosage forms common in generic pharmaceuticals. The company emphasizes its skilled workforce and dedication to employee well-being.

Manufacturer usually replies in 21 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.